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Abstract
Three-dimensional (3D) minimally invasive video-assisted thyroidectomy (MIVAT) was carried out with a 4-mm,
3D 0-degree stereoscopic endoscope. The procedure was applied on 3 patients who underwent total
thyroidectomy and data were prospectively collected. Operative time for total thyroidectomy ranged from 72 to
90 minutes. Neither intra-nor post-operative complications were reported during the study.
The surgical team noticed a good perception of depth and easy recognising of anatomic structures, especially
concerning the upper and lower vascular pedicle, the parathyroids, the superior and inferior laryngeal nerves.
Preliminary impression emerging from this study seems to suggest that 3D MIVAT is safe and effective. Future
studies with larger case series are required to determine the role of this procedure.
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Background
Minimally invasive video-assisted thyroidectomy (MIVAT),
described in 2001 by Miccoli [1], is one of the preferred
approaches used for <25-30 mL of volume thyroid.
MIVAT is currently performed using 2-dimensional
(2D) 30° 5 mm endoscopes that lack in stereoscopic vi-
sion and depth of field. The recent introduced 4 mm
3D-endoscopes seem to overcome these limits in vari-
ous surgical fields, particularly skull base, paranasal si-
nuses and neuro-surgery.
The aim of this study was to investigate the safety and
effectiveness of new 3D endoscopes applied for MIVAT
procedure.
Methods
Patients
In June 2013, three patients with multinodular goiter were
enrolled to undergo 3D MIVAT with miniature stereo-
scopic camera (Visionsense Ltd, Petach-Tikva, Israel).
This study was approved by the Institutional Review
Board of the National Cancer Institute Regina Elena of
Rome. Inclusion criteria to be admitted into the study
were: thyroid with dominant nodule less than 3 cm in
diameter, thyroid gland volume less than 25 mL, as shown
in the ultrasound, no previous neck surgery or irradiation.
All patients underwent total thyroidectomy according to
the technique described in literature [1].
Technology
A 2 cm horizontal incision was made 1 cm below the in-
ferior border of the cricoid cartilage, followed by the
MIVAT technique [1]. A 4 mm, 3D 0-degree stereoscopic
endoscope was used for the endoscopic part (Figure 1).
The Visionsense endoscopic lens was adopted during all
the procedure. It uses technology that incorporates a
microscopic array of lenses (similar to an insect’s com-
pound eye) in front of a single video chip on the end of
the scope. Multiple small images are generated and then
divided into simultaneous left and right images. Finally
the viewer’s eyes simultaneously pick up two slightly dif-
ferent images of the same object.
Assessment
Surgical team was composed by three surgeons trained
in 2D MIVAT and with an experience of at least more
than 30 MIVAT and 100 conventional thyroidectomies.
Data were collected considering clinical and pathologic
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findings, technical aspects, operative time, rate of con-
version into conventional technique and complications.
The degree of difficulty of the 3D MIVAT technique was
graded by the surgeon using a 5-point subjective scale,
ranging from 5 (very easy) to 1 (very difficult) in order
to recognize the upper and lower vascular pedicles, the
parathyroids, the superior and inferior laryngeal nerves.
Patients were asked to report their opinion according to
the cosmetic results and postoperative pain. Cosmetic
results were graded using a 4-point scale, ranging from 1
(very happy) to 4 (unhappy), while postoperative pain
was evaluated by a visual analogue scale (VAS) from 1
(no pain ever) to 10 (worse pain).
Results
Two female and 1 male with a mean age (±SD) of
44.5 years (±8.4) underwent 3D MIVAT. Mean operative
time for the total thyroidectomy was 80 minutes (range
72-90). Conversion into conventional technique was
never required. Neither intra-nor postoperative compli-
cations were observed during the study. A suction drain
was placed at the end of surgery and it was removed
when blood loss was <2 mL/hour. All patients were
discharged 24 hours after surgery. Table 1 summarizes
clinical, pathologic and operative findings. The surgical
team noticed a good perception of depth and easy
recognising of anatomic structures, especially concerning
the upper and lower vascular pedicles, the parathyroids,
the superior and inferior laryngeal nerves (Figure 2). The
recognition of these anatomic structures worsened in
presence of blood in the surgical field. This new percep-
tion of depth and volume allowed an easy use of the endo-
scope during the procedure and an intuitive manipulation
of critical structures, making comfortable and safe surgical
maneuvres using instrumentation. The negligible weight
of the handle and the absence of lateral cables made the
device light and easy to manage. The surgeons wore polar-
izing glasses without any problem even during the open
part of the surgery. No user side-effects related to the
dual-camera device were reported. Two surgeons consid-
ered the technique as very easy, while one surgeon as easy.
All patients were very happy about the cosmetic results.
Pain VAS at 1, 3 and 7 postoperative day ranged from 1 to
2 in all cases. Table 2 summarizes the subjective qualita-
tive evaluation of 3 D endoscopic system.
Discussion
MIVAT was demostrated to be a feasible and safe pro-
cedure only if selection criteria are strictly observed.
During the last decade, indications for MIVAT were
Figure 1 Minimally invasive video-assisted thyroidectomy. A view of the setting (endoscope, video camera and glasses) used for
the 3D-MIVAT.
Table 1 Clinical, pathologic and operative findings of the patients
Patients Goiter
volume (mL)
Dominant nodule major
diameter (cm)
Operative
time (min)
Intraoperative
blood loss (mL)
Postoperative
blood loss (mL)
Pathologic
findings
Hositaliztion
(days)
No. 1 20 2.8 90 45 30 Follicular
adenoma
1
No. 2 18 1.4 78 35 25 Multinodular
goiter
1
No. 3 22 1.1 72 35 10 Multinodular
goiter
1
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revised including 3.5 cm nodules in the maximum diam-
eter and 25 mL thyroid volume [1,2]. Indications were also
extended to patients with associated thyroiditis and those
with intermediate-risk differentiated thyroid cancer (DTC)
rather than those with low risk DTC [2]. After a first scep-
ticism about the procedure by some surgeons, actually,
MIVAT represents the first choice in many centres
treating thyroid disease. Complications are comparable to
the conventional technique [1], but, according to a meta-
analysis reported in literature, MIVAT needs longer opera-
tive time to be accomplished even if it is superior in terms
of immediate postoperative pain and cosmetic results
[3-5]. Nevertheless, one restriction of endoscopic or
endoscope-assisted surgery is the lack of binocular or
stereoscopic vision. Monocular endoscopes give a 2D
image that may impair depth perception, hand-eye coord-
ination, and size evaluation. Some studies in other fields
of application demonstrated that, although not in a strictly
objective way, severe mistakes made during endoscopic
procedures reflect a critical misinterpretation of the video
image rather than simply technical errors [6].
We are the first to describe the use of the 3D endo-
scope for MIVAT in a small group of patients due to
verify its safety and effectiveness in a preliminary report.
The indications and contraindications for surgery were
the same as in the 2D MIVAT. Neither complications as
hypoparathyroidism nor vocal cord paralysis were ob-
served. Conversion into conventional thyroidectomy or
reoperation for hemostasis were never required. Hospital
stay after 3D MIVAT was acceptable, not exceeding
24 hours in any case.
Quality of vision was considered optimal by all the
users except in the presence of blood in the surgical field
corresponding to a darker vision on the screen, as it
happens with 2D systems. In contrast to other experi-
ences [7,8], the glasses were still worn without disadvan-
tages when endoscope was not required. Surgeons did
not report any side-effects such as fatigue, headache, diz-
ziness, and eye strain during or after surgery.
According to some authors, stereoscopic visualization
improves depth perception, anatomical understanding,
efficiency of surgical movement, and surgeon confi-
dence. The improvement of second-generation endo-
scopic stereoscopic systems would probably improve
task performance, shorten operative time, and decrease
error rate [7,8].
This preliminary study seems to confirm that 3D
MIVAT is safe. The aim of the study was not to compare
the 3D versus the 2D technology, but to evaluate safety
and technical feasibility. A huge number of cases would
be necessary to demonstrate whether a statistical differ-
ence may exist between 2D MIVAT or 3D MIVAT in
terms of complications due to the low incidence of them
[1,3,4], while results in terms of pain and cosmetic are
expected to be similar. This paper anticipate future studies
with larger series comparing 2D and 3D MIVATaccording
to visualization and advantages in the different steps of
the procedure. Furthermore, the cost-benefit relationship
is not less important and should be investigated.
Conclusion
3D MIVAT seems to be safe and effective. A subjective
good perception in depth was acknowledged by the in-
volved surgeons without any problem in recognising crit-
ical anatomical structures. No complications were
observed and operative time was acceptable. Future
Table 2 Subjective qualitative evaluation of 3D endoscope system
Surgeons Recognition of structures
Upper vascular
pedicle
Lower vascular
pedicle
Parathyroids Superior laryngeal
nerve
Inferior laryngeal
nerve
In presence of
blood
No. 1 5 5 5 5 5 2
No. 2 5 5 5 5 5 2
No. 3 5 4 4 4 4 1
Score 5: very easy; score 4: easy; score 3: normal; score 2: difficult; score 1: very difficult.
Figure 2 An intraoperative 3D view of the operative field. The
upper vascular pedicle (white arrow) and the superior laryngeal
nerve (black arrow) on the right side are easily recognized with
good depth perception by the surgical team.
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studies with larger case series are required to determine
the role of this device.
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